HomeMy WebLinkAboutResolution - 2010-R0002 - Amending Employee Benefit Plan For Tests For Cardiovascular Disease - 01/14/2010Resolution No. 2010-R0002
January 14, 2010
Item No. 5.2
RESOLUTION
BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF LUBBOCK:
THAT the Mayor of the City of Lubbock BE and is hereby authorized and
directed to execute for and on behalf of the City of Lubbock, an Amendment to the
Employee Benefit Plan in regard to non-invasive tests for detection of cardiovascular
disease for certain at risk individuals, and related documents, and shall submit said
Amendment and documents, if any, to the City's third party administrator for use in
determining and administering employee benefits. Said Amendment is attached hereto
and incorporated in this resolution as if fully set forth herein and shall be included in the
minutes of the City Council.
Passed by the City Council this 14th
day of January , 2010.
TOM MARTIN, MAYOR
ATTEST -
CQ Z,, -
"-: � � �
Rebecc arza, City Secretary
APPROVED AS TO CONTENT:
Leisa Hutchenson, Director of Human Resources
APPROVED AS TO FORM:
Chad Weaver, Assistant City Attorney
sj ccdocs/BC BS Employee Benefit Plan Amendment 3
December 31, 2009
Resolution No. 2010-R0002
City of Lubbock
Employee Benefit Plan
Plan Amendment No. 3
This Amendment to the City of Lubbock employee Benefit Plan Document (the "Plan
Document") is executed on this, the 14th day of January, 2010, to be effective January 1, 2010.
All capitalized terms shall have the same meaning as those terms are defined in the Plan
Document. The following change is hereby made to the Plan Document:
Benefits for Coverage up to $200 (prior to deductible, co -payments or co-insurance) for
non-invasive tests for the detection of cardiovascular disease every five years for certain
at risk individuals. Tests are available to each covered individual who is (1) a male older
than 45 and younger than 76 years of age, or (2) a female older that 55 but younger that
76 years of age. The individual must be a diabetic or have a risk of developing coronary
heart disease, based on a score derived using the Framingham heart Study coronary
prediction algorithm that is intermediate or higher. The test must be performed by a
laboratory that is certified by a recognized national organization and include:
Computed tomography (CT) scanning measuring coronary artery
calcifications; or
Ultrasonography measuring carotid intima -media thickness and plaque
TOM MARTIN, Mayor
ATTEST:
Rebe Garza, City ecretary
R D AS TO CONTENT:
Leisa Hutcheson, Director Human Resources
APP ) AS TO FORM:
�7
Chad Weaver, Assistant City Attorney